Pony Testing Co., Ltd. Class A

Pony Testing Co., Ltd. Class A

SSZSE:300887
5.91
CNY
-0.14
(-2.31%)
-0.32EPS
3.79BMarket Cap
Apr 27Next Earn
2008 Y
2009 Y
2010 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.38
0.55
0.65
2.33
2.96
3.57
3.66
3.66
4.29
7.15
4.52
2.82
2.5
2.43
Basic EPS, GAAP
0.05
0.09
0.12
0.29
0.29
0.37
0.36
0.42
0.47
0.61
0.2
-0.65
-0.45
-0.32
Free Cash Flow per Basic Share
- -
- -
- -
- -
-0.23
-0.03
0.06
-0.31
-0.94
0.25
-0.42
-0.26
0.01
- -
Dividend per Share
- -
- -
0.03
0.02
0.02
0.01
0.03
0.02
0.09
0.13
0.38
0.07
- -
- -
Book Value per Share
0.09
0.16
0.21
1.55
1.81
2.19
2.53
3.89
4.31
6.49
6.33
5.62
5.17
4.93
Tangible Book Value per Share
0.08
0.15
0.2
1.44
1.59
1.98
2.33
3.73
4.03
6.17
5.69
5.02
4.84
4.71
Basic Weighted Avg Shares
245
248
306
350
351
350
352
390
468
526
546
546
546
546
Sales/Revenue/Turnover
94
136
199
817
1,039
1,251
1,287
1,426
2,007
3,762
2,468
1,541
1,365
1,326
Operating Margin (%)
16.91
20.14
20.25
13.67
12.25
12.16
12.11
14.69
13.82
11.89
11.34
-16.22
-9.61
-7.37
Depreciation Expense
- -
- -
- -
46
68
94
107
111
177
230
224
237
214
- -
Net Income, GAAP
12
22
35
100
101
128
125
164
220
323
108
-356
-246
-175
Effective Tax Rate (%)
20.14
17.16
15.33
20.46
14.08
10.58
9.63
12.13
8.57
6.27
11.59
- -
- -
- -
Profit Margin (%)
13.18
16.08
17.74
12.25
9.71
10.24
9.72
11.48
10.98
8.57
4.37
-23.12
-18.02
-13.23
Working Capital
9
17
11
196
131
183
293
990
755
1,933
1,541
1,216
1,195
1,198
LT Debt
- -
- -
- -
- -
- -
- -
38
64
50
91
79
47
71
94
Total Equity
34
56
74
544
635
769
888
1,821
2,020
3,552
3,467
3,081
2,836
2,695
Return on Invested Capital (%)
- -
45.7
45.39
27.29
16.87
17.77
13.85
11.38
10.56
10.98
3.01
- -
- -
- -
Return on Capital (%)
- -
43.95
51.18
31.24
17.1
17.83
14.24
11.43
10.63
10.96
3.07
- -
- -
- -
Return on Common Equity (%)
- -
48.8
54.07
32.35
17.1
18.23
15.09
12.09
11.47
11.6
3.08
-10.92
-8.35
-6.29

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
49
95
86
LT Borrowings
36
36
41
LT Finance Leases
58
58
53
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
546
546
546
Market Capitalization
5,457
3,798
3,793

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
1,570
1,600
1,636
Cash, Cash Equivalents & STI
834
850
850
Accounts Receivable, Net
593
585
571
Inventories
42
51
52
Total Current Liabilities
410
437
439
Payables & Accruals
- -
- -
- -
ST Debt
49
95
86
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
85.47%
13.06%
-7.97%
Free Cash Flow
- -
-55.51%
-102.22%
Net Income, GAAP
-20.74%
-89.43%
-30.97%
Sales/Revenue/Turnover
41.64%
8.96%
-11.44%
Total Cash Common Dividend
- -
130.27%
-93.75%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
334
394
395
418
1,541
2025
252
313
- -
433
1,365
2026
263
306
324
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.18
-0.13
-0.11
-0.22
-0.65
2025
-0.2
-0.13
- -
-0.09
-0.45
2026
-0.13
-0.06
-0.05
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
0.01
0.06
- -
0.07
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

CEO
Ying Jie Zhang
Full Time Employees
5,393
Sector
Commercial services
Industry
Miscellaneous commercial services
Address
Beijing China
IPO Date
Sep 16, 2020
Business
Pony Testing International Group Co., Ltd. is a comprehensive third-party testing, inspection, certification, and technical services provider based in China. Founded in 2002 and headquartered in Beijing, the company provides integrated analytical solutions and quality assurance services across diverse industrial sectors, serving corporate enterprises, research organizations, and regulatory bodies. The company operates an extensive nationwide network of testing bases and specialized laboratories, delivering systematic services that include: life science and healthcare solutions, comprising pharmaceutical contract research and contract development and manufacturing organization (CRO/CDMO) services, active pharmaceutical ingredient testing, clinical and pathological diagnostic testing, toxicology evaluations, biocompatibility assessments, and full-lifecycle medical device verification; food and agricultural product analysis, covering pesticide and veterinary drug residue screening, microbiological examination, nutritional component testing, and food contact material compliance; environmental protection and sustainability services, including ambient air, surface water, groundwater, and soil quality monitoring, ecological risk assessments, hazardous waste identification, ionizing radiation testing, energy-efficiency evaluation, and carbon footprint and carbon neutrality consulting; automotive and new energy testing, providing safety, electromagnetic compatibility (EMC), environmental reliability, and material durability testing for conventional vehicles, new energy vehicles, automotive power batteries, and charging infrastructure; consumer goods and chemical testing, consisting of textile, apparel, footwear, toy, cosmetic efficacy evaluation, cosmetic safety verification, and electronic and electrical product compliance testing; and industrial and engineering services, encompassing metrological calibration, special equipment inspection, factory quality audits, and international market certification support. In recent developments, Pony Testing has strategically accelerated the expansion of high-value business lines by scaling its GLP- and AAALAC-accredited biopharmaceutical CRO/CDMO infrastructure, initiating the Phase II construction of its active pharmaceutical ingredient facility in Hubei, and expanding large-animal and reusable medical device testing capabilities. The company has also deepened strategic partnerships with leading automotive and battery manufacturers to provide comprehensive testing across the entire battery lifecycle and to support domestic electric vehicle makers expanding into overseas markets. Furthermore, Pony Testing broadened its footprint in special equipment and elevator inspection through strategic acquisitions, including the acquisition of Dingshengxin Testing, while expanding technical capabilities into specialized fields such as ionizing radiation detection.